Suzhou Zelgen Biopharmaceuticals Co Ltd Capital Reinvestment Ratio
Suzhou Zelgen Biopharmaceuticals Co Ltd capital reinvestment ratio. Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) has a Capital Reinvestment Ratio of 97.08x as of September 2025, meaning it reinvests 97% of its operating cash flow (CN¥543.69K) in capital expenditures (CN¥52.78 Million). Check cash flow reinvestment rate of Suzhou Zelgen Biopharmaceuticals Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Suzhou Zelgen Biopharmaceuticals Co Ltd (2024–2024)
Capital reinvestment ratio of Suzhou Zelgen Biopharmaceuticals Co Ltd from 2024 to 2024. This chart tracks Suzhou Zelgen Biopharmaceuticals Co Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore Suzhou Zelgen Biopharmaceuticals Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Suzhou Zelgen Biopharmaceuticals Co Ltd Capital Reinvestment Ratio by Year (2024–2024)
Suzhou Zelgen Biopharmaceuticals Co Ltd capital reinvestment ratio by year from 2024 to 2024. For the full cash flow conversion analysis, see cash flow conversion of Suzhou Zelgen Biopharmaceuticals Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.50x | CN¥38.20 Million | CN¥95.69 Million | — |